Olga Kovalenko MD

PubMed

• 28 citations
  The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer.
  Anil Belur Nagaraj, Matthew Knarr, Sreeja C. Sekhar, R. Shae Connor, Peronne Joseph
  Cancer Research. 2021-04-15
• 3 citations
  Hyperhomocysteinemia and Pulmonary Embolism in a Young Male.
  Olga Kovalenko, Ahmad Nader Kassem, Melissa Jenkins
  Cureus. 2020-04-24
• 9 citations
  Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.
  Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, QuanQiu Wang, Rong Xu
  Gynecologic Oncology. 2018-12-01

Journal Articles

• The miR–181a–SFRP4 Axis Regulates Wnt Activation to Drive Stemness and Platinum Resistance in Ovaria  
  Belur Nagaraj, A, Knarr M, Sekhar S, Connor R, Joseph P, Kovalenko O, Fleming A, Surti A, Nurmemmedov E, Beltrame L Marchini S, Kahn M, Difeo A, Cancer Research, 4/2021
• Hyperhomocysteinemia and Pulmonary Embolism in a Young Male  
  Kovalenko O, Kassem AN, Jenkins M, Cureus, 2020
• Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer.  
  Belur Nagaraj A, Joseph P, Kovalenko O, Wang Q, Xu R, DiFeo A, Gynecol Oncol, 2018
• Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer.  
  Belur Nagaraj A, Kovalenko O, Avelar R, Joseph P, Brown A, Surti A, Mantilla S, DiFeo A, Clin Cancer Res, 2018
• Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.  
  Nagaraj AB, Wang QQ, Joseph P, Zheng C, Chen Y, Kovalenko O, Singh S, Armstrong A, Resnick K, Zanotti K, Waggoner S, Xu R, DiFeo A, Oncogene, 2017
• Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.  
  Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A, Oncotarget, 2015
• Join now to see all

Abstracts/Posters

• Prolonged total treatment times and associated factors in a cohort of patients with locally advanced cervical cancer
  Olga Kovalenko, Stacy Smrz, Jennifer Gordon, Fredrick R. Schumacher, Amy Armstrong, Society of Gynecologic Oncology, San Diego, CA, 2024
• Changes in Vulvar Cancer Incidence From Before COVID-19 Through the First Year of the Pandemic
  Allison B Reid; Olga Kovalenko; Jennifer Gordon; Lindsay Ferguson, Society of Gynecologic Oncology, Phoenix, Arizona, 2022
• Geospatial Approaches for Surveillance of Disparities in Clinical Trial Enrollment
  Gordon, J, Curtis J, Kovalenko O, Miller AK, Ajayakumar J, Smrz S, Schumacher FR, Avril S., Society of Gynecologic Oncology, Phoenix, AZ, 2022